Katsu 1993.
| Methods | Double‐blind, double‐dummy, head‐to‐head comparison, natural colds | |
| Participants | 167 adults, mean age, sex not reported for the subgroup of colds, 32 centres, outpatient departments of hospitals and clinics, moderate to severe URTI, not requiring antibiotics | |
| Interventions | 2 groups: loxoprofen 180 mg/day and ibuprofen 600 mg for 3 days | |
| Outcomes | No significant difference in FGIR between 2 groups | |
| Notes | No available data on adverse effects for the subgroup of common colds | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | "... were randomly assigned to receive" Comment: insufficient information about the sequence generation process |
| Allocation concealment (selection bias) | Unclear risk | Comment: insufficient information about the allocation concealment |
| Blinding (performance bias and detection bias) All outcomes | Low risk | "... double‐blind, double‐dummy method...active drug and placebo were quite similar in shape (in Japanese)" Comment: probably done |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | "112/130 of the CS‐600 group and 113/132 group were evaluated in the assessment improvement ratings" Comment: there are no reasons for missing participants. Insufficient reporting of attrition/exclusions to permit judgement |
| Selective reporting (reporting bias) | Unclear risk | No protocol, no convincing text |
| Other bias | Low risk | The study appears to be free of other sources of bias |